ImmunityBio Inc. (IBRX)
NASDAQ: IBRX
· Real-Time Price · USD
2.61
-0.10 (-3.69%)
At close: Aug 15, 2025, 11:37 AM
ImmunityBio Revenue
ImmunityBio reported an annual revenue of $14.74M, reflecting a 2270.58% growth. For the quarter ending June 30, 2025, ImmunityBio generated $26.43M in revenue.
Revenue (ttm)
14.74M
Revenue Growth
2270.58%
Price / Sales Ratio
121.07
Revenue / Employee
21.97K
Employees
671
Market Cap
2.46B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|